$130.95
Q4312 identifies Acesso AC, not Dermabind FM. Select the product-specific code for the product supplied.
On this page
CMS RVU26D · Effective 2026-10-01
Q4313 Wound product Medicare reimbursement rates in Minnesota
Dermabind FM is a wound-covering skin substitute product reported by square centimeter with a qualifying wound application procedure. Compare Q4313 office and facility rates across CMS payment localities in Minnesota.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for Q4313 in Minnesota?
Minnesota has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$130.95
1 of 1 localities have a supported rate.
Payment area: Minnesota
One mapped payment locality.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Skin substitute product
About Q4313: Dermabind FM wound product
Dermabind FM is a wound-covering skin substitute product reported by square centimeter with a qualifying wound application procedure.
Q4313 identifies Dermabind FM supplied for wound coverage, with quantity measured in square centimeters. It represents the product, not wound preparation or the clinician’s application service. Wound-care physicians, surgeons, and other clinicians treating open wounds may use the product in office or hospital outpatient settings. The product code follows the Dermabind FM used, rather than the wound’s location or a particular diagnosis.
Report Q4313 only with a primary wound application procedure, selecting the applicable procedure based on the treated site and wound area. The record should identify Dermabind FM and support the quantity reported in square centimeters. CMS treats Q4313 as an add-on: payment is made with the primary procedure and within that procedure’s global period. CMS classifies the code as technical-component-only, with interpretation represented by a separate code.
CMS billing rules for Q4313
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
- Professional and technical components
- Technical-component-only code: a separate code covers interpretation.
Where the value comes from
- Work RVU0.00 · 0%
- Practice expense (office) RVU3.81 · 100%
- Malpractice RVU0.00 · 0%
11.1K
Medicare services in 2024 · #1424 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Q4313 compared with similar codes
Office rates for Minnesota, from the same CMS release.
$130.95
Q4314 identifies Reeva. Its per-square-centimeter unit does not make it interchangeable with Dermabind FM.
Q4310
No office rateProcenta, per 100 mg
Q4310 identifies Procenta and is reported per 100 mg; Q4313 identifies Dermabind FM and is measured per square centimeter.
Compare Q4313 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Minnesota →
Office / nonfacility
$130.95
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for Q4313 in Minnesota.
PPRRVU2026_Oct_nonQPP.csv
18,400
- Code
- Q4313
- Physician work
- 0.00
- Practice expense
- 3.81
- Malpractice
- 0.00
GPCI2026.csv
66
- Locality
- Minnesota
- Physician work
- 1.000
- Practice expense
- 1.029
- Malpractice
- 0.296
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.00 | × 1.000 | 0.0000 |
| Practice expense | 3.81 | × 1.029 | 3.9205 |
| Malpractice | 0.00 | × 0.296 | 0.0000 |
| Total RVUs | 3.9205 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Minnesota$130.95
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0 | 1 |
| Practice expense | 3.81 | 1.029 |
| Malpractice | 0 | 0.296 |
(0 × 1 + 3.81 × 1.029 + 0 × 0.296) × $33.4009 = $130.95
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
Q4313 billing questions
Does Q4313 include the wound application service?
No. Q4313 identifies the Dermabind FM product; report it with the appropriate primary wound application procedure, such as a code in the 15271–15278 series.
How do I select the primary application code?
Choose the application procedure based on the wound site and treated area. For example, 15271 and 15275 apply to different anatomic site groupings.
How many units should I report?
Report the Dermabind FM quantity in square centimeters. Documentation should support the product and the amount used.
Is interpretation included in Q4313?
CMS classifies Q4313 as technical-component-only; a separate code covers interpretation.
Can I report Q4313 by itself?
No. CMS identifies it as an add-on code, so it is billed with a primary procedure and paid within that procedure’s global period.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
18,397Q4310,,"Procenta, per 100 mg",C,,0.00,0.00,,0.00,,0.00,0.00,0.00,3,XXX,0.00,0.00,0.00,9,9,9,9,9,9,,33.4009,09,0,99,0.00,0.00,0.00
18,398Q4311,,"Acesso, per sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,399Q4312,,"Acesso ac, per sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,400Q4313,,"Dermabind fm, per sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,401Q4314,,"Reeva, per sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,402Q4315,,Regenelink amniotic mem allo,A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,403Q4316,,"Amchoplast, per sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
6314212,MA,99,REST OF MASSACHUSETTS,1.016,1.053,0.797
6408202,MI,01,DETROIT,1.000,0.965,1.686
6508202,MI,99,REST OF MICHIGAN,1.000,0.913,1.129
6606202,MN,00,MINNESOTA,1.000,1.029,0.296
6707302,MS,00,MISSISSIPPI,1.000,0.861,0.739
6805302,MO,02,METROPOLITAN KANSAS CITY,1.000,0.939,0.977
6905302,MO,01,METROPOLITAN ST. LOUIS,1.000,0.952,1.002